top of page

S6: 8:15 - 8:30 Videos


Presenter: Dr. Stephen Scholand


Method: Several short videos will be shown, which supplement the themes of the other
sessions. Time for group discussion is deferred.


Objectives:

​

Think about race and racism in the context of healthcare delivery and global health​

1.

From race-based to race-conscious medicine: how anti-racist uprisings call us to act. A Perspective in The Lancet, from Jessica P Cerdeña, Marie V Plaisime, and Jennifer Tsai.

2.

African countries import 99% of their vaccines and although Africa has around ten vaccine manufacturers, most do not make a vaccine’s active ingredients, but instead ‘fill and finish’ imported products. A lack of manufacturing is one reason that only 11% of the continent’s people have been fully vaccinated against COVID-19. Mutual respect is a simple principle; Isn’t it about time?

In mid-May 2021, South Africa began vaccinating citizens over age 60 against COVID-19, the second group to be prioritized, after healthcare workers. Unfortunately, it has only vaccinated one percent of its population, and the demands are great. There are only 87 vaccination centers across the entire nation.

Supplementary materials:


Africa in Focus Vaccine Inequity: Ensuring Africa is not left out

https://www.brookings.edu/blog/africa-in-focus/2022/01/24/vaccine-inequity-ensuring-africa-is-not-left-out/

 

 

​

Feedback:
Please complete the feedback form for this session:
S6. Video session feedback form.

S7: 8:30-10:30 Chagas Disease


Lead: Dr. Norm Beatty

​

Method: Interactive


Objectives:
 

Discussion will include an overview of Chagas disease, how diseases connect the global south and north, and how climate change is changing the distribution of vectors.


Opportunity to view specimens of reduviid bugs (kissing bugs) - the vector of Trypanosoma cruzi, the pathogen that causes Chagas disease.

 

Questions:


What is the concept of One Health? What is the potential for further pandemics and zoonotic diseases due to increased human animal and human-environmental interfaces? What, if anything, can be done to counteract this?

 

Link to powerpoint presentation:

https://docs.google.com/presentation/d/1j1zRbFSkWydLizmfmx9b3SuskjQlfgrm/edit?usp=sharing&ouid=108198105988285894623&rtpof=true&sd=true

​

Supplementary Materials:

 

  1. Forsyth CJ, et al. Recommendations for Screening and Diagnosis of Chagas Disease in the United States. J Infect Dis. 2022 May 4;225(9):1601-1610. doi: 10.1093/infdis/jiab513. PMID: 34623435; PMCID: PMC907134     https://pubmed.ncbi.nlm.nih.gov/34623435/

  2. Beatty NL, Klotz SA. Autochthonous Chagas Disease in the United States: How Are People Getting Infected? Am J Trop Med Hyg. 2020 Sep;103(3):967-969. doi: 10.4269/ajtmh.19-0733. PMID: 32602437; PMCID: PMC7470559.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470559/

​

S8: 10:30-11:30 “Public Health Emergency of International Concern (PHEIC)


SARS-CoV-2, Monkeypox, and Polio”


Q/A Session with Drs. Norm Beatty, Stephen Scholand, and Alex Kayongo
 

Lead: Dr. Majid Sadigh

 

Method: After a brief introductory remark by the moderator, students will go over discussion questions which will then be discussed jointly with the panel. Finally a Q & A will be held with the panelists.

Objectives:


To gain a basic understanding of the current outbreaks of SARS-CoV-2, Monkeypox,
and Polio in the United States, and to recognize potential future PHEIC.

Discussion Questions:

 

  1. Why couldn’t we contain the SARS-CoV-2 pandemic?

  2. Why is Monkeypox a global health threat?

  3. How did the poliomyelitis virus reach New York City?

  4. Why has Polio become a re-emergent public health and global health concern? Suggest strategies to address this. Is there a risk of other diseases that have been considered ‘eradicated’ re-emerging? Why is this so?

  5. Should we use IPV or OPV to contain and eliminate the current polio situation in the USA?

  6. Vaccine hesitancy presents problems in public health and has an unequal prevalence. Why are some countries more vaccine hesitant than others? What can be done to counteract this?

  7. There has been an unequal response and impact of SARS-CoV-2 around the globe. What are the social determinants of health and why are they relevant when considering a pandemic? (refer to Sir Michael Marmot - Building Back Fairer)

  8. The impact of recent pandemics on health systems has created challenges, including with regard to non-communicable diseases. Why have non-communicable disease strategies been impacted by the recent pandemic? What can be done to mitigate this?

​​

Supplementary Materials:


Watch the Following Videos:

  1. Polio in New York

  2. "Why Monkeypox Is a Global Health Threat | WSJ"

  3. Monkeypox Clinical Update

  4. Dr. Michael Osterholm on COVID-19, variants, vaccines and more

​

Feedback:
Please complete the feedback form for this session
"Public Health Emergency of International Concern" session feedback form.

S9: 11:30-12:50 Global Health as a Career
 

Lead: Dr. Stephen Scholand

​

Objectives:
 

The purpose of this session is 2-fold:

 

  1. to discuss what working in global health might look like

  2. discuss the ethics of working abroad
     

Panelists

 

  • Chantal Perera

  • Krystal Gopaul

  • Jett Choquette

  • Dr. Norman Beatty

  • Dr. Bulat Ziganshin

 

 

Supplementary materials:

 

https://globalvolunteers.org/ethical-volunteer-vacations/

https://www.cdc.gov/globalhealth/employment/default.htm

https://www.cugh.org/online-tools/job-board/

 

 

​

Feedback:
Please complete the feedback form for this session
S9. Global Health as a Career session feedback form.

bottom of page